GSK Statistics
Share Statistics
GSK has 2.04B shares outstanding. The number of shares has increased by -0.88% in one year.
| Shares Outstanding | 2.04B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.04B |
| Failed to Deliver (FTD) Shares | 113.28K |
| FTD / Avg. Volume | 1.94% |
Short Selling Information
The latest short interest is 16.29M, so 0.8% of the outstanding shares have been sold short.
| Short Interest | 16.29M |
| Short % of Shares Out | 0.8% |
| Short % of Float | 0.8% |
| Short Ratio (days to cover) | 3.29 |
Valuation Ratios
The PE ratio is 11.92 and the forward PE ratio is 8.26. GSK's PEG ratio is 0.28.
| PE Ratio | 11.92 |
| Forward PE | 8.26 |
| PS Ratio | 1.94 |
| Forward PS | 2.1 |
| PB Ratio | 4.4 |
| P/FCF Ratio | 13.28 |
| PEG Ratio | 0.28 |
Enterprise Valuation
GSK has an Enterprise Value (EV) of 133.16B.
| EV / Earnings | 27.02 |
| EV / Sales | 4.39 |
| EV / EBITDA | 14.66 |
| EV / EBIT | 19.74 |
| EV / FCF | 30.1 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 1.26.
| Current Ratio | 0.88 |
| Quick Ratio | 0.62 |
| Debt / Equity | 1.26 |
| Total Debt / Capitalization | 55.74 |
| Cash Flow / Debt | 0.4 |
| Interest Coverage | 8.7 |
Financial Efficiency
Return on equity (ROE) is 0.37% and return on capital (ROIC) is 19.16%.
| Return on Equity (ROE) | 0.37% |
| Return on Assets (ROA) | 0.08% |
| Return on Capital (ROIC) | 19.16% |
| Revenue Per Employee | 431.95K |
| Profits Per Employee | 70.19K |
| Employee Count | 70.21K |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | 756.00M |
| Effective Tax Rate | 0.12 |
Stock Price Statistics
The stock price has increased by -5.41% in the last 52 weeks. The beta is 0.33, so GSK's price volatility has been higher than the market average.
| Beta | 0.33 |
| 52-Week Price Change | -5.41% |
| 50-Day Moving Average | 36.36 |
| 200-Day Moving Average | 40.31 |
| Relative Strength Index (RSI) | 41.8 |
| Average Volume (20 Days) | 5.83M |
Income Statement
In the last 12 months, GSK had revenue of $30.33B and earned $4.93B in profits. Earnings per share was $1.2.
| Revenue | 30.33B |
| Gross Profit | 21.76B |
| Operating Income | 6.75B |
| Net Income | 4.93B |
| EBITDA | 9.08B |
| EBIT | 6.75B |
| Earnings Per Share (EPS) | 1.2 |
Balance Sheet
The company has $2.75B in cash and $18.02B in debt, giving a net cash position of -$15.27B.
| Cash & Cash Equivalents | 2.75B |
| Total Debt | 18.02B |
| Net Cash | -15.27B |
| Retained Earnings | 7.74B |
| Total Assets | 58.05B |
| Working Capital | -4.16B |
Cash Flow
In the last 12 months, operating cash flow was $6.77B and capital expenditures -$2.34B, giving a free cash flow of $4.42B.
| Operating Cash Flow | 6.77B |
| Capital Expenditures | -2.34B |
| Free Cash Flow | 4.42B |
| FCF Per Share | 1.09 |
Margins
Gross margin is 71.76%, with operating and profit margins of 22.24% and 16.25%.
| Gross Margin | 71.76% |
| Operating Margin | 22.24% |
| Pretax Margin | 19.99% |
| Profit Margin | 16.25% |
| EBITDA Margin | 29.95% |
| EBIT Margin | 22.24% |
| FCF Margin | 14.59% |
Dividends & Yields
GSK pays an annual dividend of $1.56, which amounts to a dividend yield of 4.57%.
| Dividend Per Share | $1.56 |
| Dividend Yield | 4.57% |
| Dividend Growth (YoY) | 14.78% |
| Payout Ratio | 100.65% |
| Earnings Yield | 3.54% |
| FCF Yield | 6.39% |
Analyst Forecast
The average price target for GSK is $45.5, which is 34.1% higher than the current price. The consensus rating is "Hold".
| Price Target | $45.5 |
| Price Target Difference | 34.1% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Jul 22, 2022. It was a backward split with a ratio of 4:5.
| Last Split Date | Jul 22, 2022 |
| Split Type | backward |
| Split Ratio | 4:5 |
Scores
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 6 |